EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicans

Pétra Vande Zande iD, Cécile Gautier, Nora Kawar, Corinne Maufrais, Katura Metzner, Elizabeth Wash, Annette K Beach, Ryan Bracken, Eli Isael Maciel, Nívea Pereira de Sá, Caroline Mota Fernandes, Norma V Solis und 5 weitere

PLOS Pathogens · 30.08.2024 · 20 (8) · e1012497

DOI: 10.1371/journal.ppat.1012497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 30.08.2024. Verfasst von Pétra Vande Zande und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America. Hauptthemen laut MEDLINE: Antifungal Agents, Candida albicans, Drug Resistance, Fungal, Fungal Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial drug resistance poses a global health threat, requiring a deeper understanding of the evolutionary processes that lead to its emergence in pathogens. Complex evolutionary dynamics involve multiple mutations that can result in cooperative or competitive (clonal interference) effects. Candida albicans , a major fungal pathogen, displays high rates of copy number variation (CNV) and loss of heterozygosity (LOH). CNV and LOH events involve large numbers of genes and could synergize during evolutionary adaptation. Understanding the contributions of CNV and LOH to antifungal drug adaptation is challenging, especially in the context of whole-population genome sequencing. Here, we document the sequential evolution of fluconazole tolerance and then resistance in a C . albicans isolate involving an initial CNV on chromosome 4, followed by an LOH on chromosome R that involves KSR1 . Similar LOH events involving KSR1 , which encodes a reductase in the sphingolipid biosynthesis pathway, were also detected in independently evolved fluconazole resistant isolates. We dissect the specific KSR1 codons that affect fluconazole resistance and tolerance. The combination of the chromosome 4 CNV and KSR1 LOH results in a >500-fold decrease in azole susceptibility relative to the progenitor, illustrating a compelling example of rapid, yet step-wise, interplay between CNV and LOH in drug resistance evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandida albicansDrug Resistance, FungalFungal ProteinsLoss of HeterozygosityAzolesCandidiasisDNA Copy Number VariationsEvolution, MolecularFluconazoleMicrobial Sensitivity Tests

Substanzen

Antifungal AgentsAzolesFluconazoleFungal Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Institut Pasteur, Université Paris Cité, Fungal Heterogeneity Group, Paris, France.
  • Shmunis School of Biotechnology and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel.
  • Institut Pasteur Bioinformatic Hub, Université Paris Cité, Paris, France.
  • Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
  • Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States of America.

ORCID-Profile: Pétra Vande Zande, Anna Selmecki

Förderung

  • BLRD VA
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Burroughs Wellcome Fund
  • H2020 European Research Council
  • ANR GENOMEHET
  • PTR Carnot Pasteur
  • U.S. Department of Veterans Affairs

Zitieren

APA

Vande Zande, P., Gautier, C., Kawar, N., Maufrais, C., Metzner, K., Wash, E., Beach, A. K., Bracken, R., Maciel, E. I., Pereira de Sá, N., Fernandes, C. M., Solis, N. V., Del Poeta, M., Filler, S. G., Berman, J., Ene, I. V., & Selmecki, A. (2024). Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicans. PLOS Pathogens, 20(8), e1012497. https://doi.org/10.1371/journal.ppat.1012497

Vancouver

Vande Zande P, Gautier C, Kawar N, Maufrais C, Metzner K, Wash E, et al. Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicans. PLOS Pathogens. 2024;20(8):e1012497. doi:10.1371/journal.ppat.1012497

BibTeX
@article{VandeZande2024,
  author = {Vande Zande, Pétra and Gautier, Cécile and Kawar, Nora and Maufrais, Corinne and Metzner, Katura and Wash, Elizabeth and Beach, Annette K and Bracken, Ryan and Maciel, Eli Isael and Pereira de Sá, Nívea and Fernandes, Caroline Mota and Solis, Norma V and Del Poeta, Maurizio and Filler, Scott G and Berman, Judith and Ene, Iuliana V and Selmecki, Anna},
  title = {Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicans},
  journal = {PLOS Pathogens},
  year = {2024},
  volume = {20},
  number = {8},
  pages = {e1012497},
  doi = {10.1371/journal.ppat.1012497}
}
Kostenlos starten →